101 related articles for article (PubMed ID: 23688766)
1. [Hotspot report of 54th American Society of Hematology Annual Meeting--the principle and clinical application of Bruton tyrosine kinase inhibitor].
Liu HM; Zhang YR; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):471-2. PubMed ID: 23688766
[No Abstract] [Full Text] [Related]
2. Which tyrosine kinase inhibitor, if any?
Ruiz-Arguelles GJ
Clin Adv Hematol Oncol; 2011 Nov; 9(11):878-9. PubMed ID: 22252622
[No Abstract] [Full Text] [Related]
3. [Hotspot report of the 54th American Society of Hematology Annual Meeting Drug resistance of multiple myeloma].
Hao M; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):374-6. PubMed ID: 23668218
[No Abstract] [Full Text] [Related]
4. Tyrosine kinase inhibitors in pediatric malignancies.
Skolnik JM; Adamson PC
Cancer Invest; 2007; 25(7):606-12. PubMed ID: 17952738
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer.
Carmi C; Mor M; Petronini PG; Alfieri RR
Biochem Pharmacol; 2012 Dec; 84(11):1388-99. PubMed ID: 22885287
[TBL] [Abstract][Full Text] [Related]
6. Integrating clinical pharmacology concepts in individualized therapy with tyrosine kinase inhibitors.
Drenberg CD; Baker SD; Sparreboom A
Clin Pharmacol Ther; 2013 Mar; 93(3):215-9. PubMed ID: 23419484
[TBL] [Abstract][Full Text] [Related]
7. [Clinical results observed with tyrosine kinase inhibitors].
Pérol M
Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S7-9. PubMed ID: 17242636
[No Abstract] [Full Text] [Related]
8. [Can chronic myeloid leukemia be cured by tyrosine kinase inhibitor?].
Li MQ; Liu ZG
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):725-8. PubMed ID: 23978030
[No Abstract] [Full Text] [Related]
9. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shamroe CL; Comeau JM
Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264
[TBL] [Abstract][Full Text] [Related]
10. [Development of tyrosine kinase inhibitors for hematologic neoplasms. FLT3 and JAK2 as therapeutic targets].
Lipka D; Heidel F; Huber C; Fischer T
Pharm Unserer Zeit; 2008; 37(5):394-403. PubMed ID: 18729264
[No Abstract] [Full Text] [Related]
11. Playing Russian roulette with tyrosine kinase inhibitors.
Szmulewitz RZ; Ratain MJ
Clin Pharmacol Ther; 2013 Mar; 93(3):242-4. PubMed ID: 23340477
[No Abstract] [Full Text] [Related]
12. [Protein tyrosine kinase inhibitors in cancer therapy].
Boutayeb S; Zakkouri FZ; Aitelhaj M; Mesmoudi M; Boutayeb A; Boutayeb W; Mrabti H; Errihani H
Pathol Biol (Paris); 2012 Aug; 60(4):229-33. PubMed ID: 22743095
[TBL] [Abstract][Full Text] [Related]
13. [Use of tyrosine kinase inhibitors in particular situations].
Quoix E
Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S14-5. PubMed ID: 17242639
[No Abstract] [Full Text] [Related]
14. Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia.
Craig J; Walker K; Sales M; Cunningham J; Gelly K; Pippard MJ; Tauro S
Br J Haematol; 2008 Aug; 142(4):674-5. PubMed ID: 18485048
[No Abstract] [Full Text] [Related]
15. [Protein tyrosine kinases as drug targets. An important group of intracellular regulators].
Winckler T; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2008; 37(5):370-80. PubMed ID: 18729262
[No Abstract] [Full Text] [Related]
16. Small molecule tyrosine kinase inhibitor and depression.
Quek R; Morgan JA; George S; Butrynski JE; Polson K; Meyer F; Demetri GD; Block SD
J Clin Oncol; 2009 Jan; 27(2):312-3. PubMed ID: 19064960
[No Abstract] [Full Text] [Related]
17. Meeting report: targeting the kinome--20 years of tyrosine kinase inhibitor research in Basel.
Bozulic L; Morin P; Hunter T; Hemmings BA
Sci STKE; 2007 Feb; 2007(374):pe8. PubMed ID: 17317657
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinases as targets for cancer therapy.
Krause DS; Van Etten RA
N Engl J Med; 2005 Jul; 353(2):172-87. PubMed ID: 16014887
[No Abstract] [Full Text] [Related]
19. ALK inhibitors in lung cancer.
Heath E
Clin Adv Hematol Oncol; 2009 Oct; 7(10):649-50. PubMed ID: 20040904
[No Abstract] [Full Text] [Related]
20. [Associations of tyrosine kinase inhibitors with chemotherapy].
Bréchot JM
Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S12-3. PubMed ID: 17242638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
